{"url_path":"/sec/tlsiw/8-k/2026-05-12/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1826667/0001628280-26-034082-index.html","accession_number":"0001628280-26-034082","cik":"0001826667","ticker":"TLSI","issuer_name":"TriSalus Life Sciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1826667/0001628280-26-034082-index.html","primary_entity_key":"0001826667","primary_entity_name":"TriSalus Life Sciences, Inc."},"word_count":76,"has_tables":true,"body_markdown":"Item 9.01Financial Statements and Exhibits.\n\n(d) Exhibits:\n\nExhibit NumberDescription\n\n[99.1](q12026earningsrelease.htm)\n\nPress Release dated May 12, 2026\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: May 12, 2026\nTriSalus Life Sciences, Inc.\n\nBy:/s/ David Patience\n\nName:David Patience\n\nTitle:Chief Financial Officer"}